CATHERINE FAIRCLOTH: Open Payments
NPI 1386320349 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 22 payments from 10 companies in 2025. Trend: 2023 $689 · 2024 $1,555 · 2025 $449
Food & beverage: $444Education: $5
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $147 |
| Daiichi Sankyo Inc. | 2 | $52 |
| AKEBIA THERAPEUTICS INC | 2 | $50 |
| Travere Therapeutics, Inc. | 5 | $47 |
| Amgen Inc. | 2 | $46 |
| Ardelyx, Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $23 |
| FRESENIUS USA MANUFACTURING, INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Calliditas Therapeutics US Inc. | 1 | $17 |
Products named: JYNARQUE, INJECTAFER, Vafseo, KRYSTEXXA, IBSRELA, Ozempic, VELPHORO, AREXVY.
Industry payments across GA — which companies pay providers there.
